Concepedia

Anjushree Iyer

AI

Statistics

Publications

2

Citations

41

H-Index

2

Active since

2023

Affiliations

NGM Biopharmaceuticals (United States)(Current)

Anjushree Iyer is an author at NGM Biopharmaceuticals (United States) specializing in oncology, biomarker-guided immunotherapy, and immunology.

ORCID

Publications per year

2023–2024

2

Publications

2

A target discovery pipeline identified ILT3 as a target for immunotherapy of multiple myeloma

Francesco Di Meo, Anjushree Iyer, Keith T. Akama et al. · Cell Reports Medicine · 2023 · 27 citations · Full text

, , +17

ILT2 and ILT4 Drive Myeloid Suppression via Both Overlapping and Distinct Mechanisms

Jane Tian, Amir M. Ashique, Sabrina Weeks et al. · Cancer Immunology Research · 2024 · 14 citations

, , +17

1–2 of 2